Literature DB >> 26843485

p38γ and p38δ reprogram liver metabolism by modulating neutrophil infiltration.

Bárbara González-Terán1, Nuria Matesanz1, Ivana Nikolic1, María Angeles Verdugo2, Vinatha Sreeramkumar1, Lourdes Hernández-Cosido3, Alfonso Mora1, Georgiana Crainiciuc1, María Laura Sáiz1, Edgar Bernardo1, Luis Leiva-Vega1, Elena Rodríguez1, Victor Bondía1, Jorge L Torres4, Sonia Perez-Sieira5, Luis Ortega3, Ana Cuenda6, Francisco Sanchez-Madrid1, Rubén Nogueiras5, Andrés Hidalgo1, Miguel Marcos4, Guadalupe Sabio7.   

Abstract

Non-alcoholic fatty liver disease (NAFLD) is a major health problem and the main cause of liver disease in Western countries. Although NAFLD is strongly associated with obesity and insulin resistance, its pathogenesis remains poorly understood. The disease begins with an excessive accumulation of triglycerides in the liver, which stimulates an inflammatory response. Alternative p38 mitogen-activated kinases (p38γ and p38δ) have been shown to contribute to inflammation in different diseases. Here we demonstrate that p38δ is elevated in livers of obese patients with NAFLD and that mice lacking p38γ/δ in myeloid cells are resistant to diet-induced fatty liver, hepatic triglyceride accumulation and glucose intolerance. This protective effect is due to defective migration of p38γ/δ-deficient neutrophils to the damaged liver. We further show that neutrophil infiltration in wild-type mice contributes to steatosis development by means of inflammation and liver metabolic changes. Therefore, p38γ and p38δ in myeloid cells provide a potential target for NAFLD therapy.
© 2016 The Authors.

Entities:  

Keywords:  diabetes; inflammation; obesity; steatosis; stress kinases

Mesh:

Substances:

Year:  2016        PMID: 26843485      PMCID: PMC4772851          DOI: 10.15252/embj.201591857

Source DB:  PubMed          Journal:  EMBO J        ISSN: 0261-4189            Impact factor:   11.598


  34 in total

1.  Fast food diet mouse: novel small animal model of NASH with ballooning, progressive fibrosis, and high physiological fidelity to the human condition.

Authors:  Michael Charlton; Anuradha Krishnan; Kimberly Viker; Schuyler Sanderson; Sophie Cazanave; Andrea McConico; Howard Masuoko; Gregory Gores
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2011-08-11       Impact factor: 4.052

2.  E-selectin supports neutrophil rolling in vitro under conditions of flow.

Authors:  O Abbassi; T K Kishimoto; L V McIntire; D C Anderson; C W Smith
Journal:  J Clin Invest       Date:  1993-12       Impact factor: 14.808

Review 3.  Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults.

Authors:  G Vernon; A Baranova; Z M Younossi
Journal:  Aliment Pharmacol Ther       Date:  2011-05-30       Impact factor: 8.171

4.  Alternative p38 MAPKs are essential for collagen-induced arthritis.

Authors:  Gabriel Criado; Ana Risco; Dayanira Alsina-Beauchamp; María J Pérez-Lorenzo; Alejandra Escós; Ana Cuenda
Journal:  Arthritis Rheumatol       Date:  2014-05       Impact factor: 10.995

Review 5.  Nonalcoholic fatty liver disease: from steatosis to cirrhosis.

Authors:  Geoffrey C Farrell; Claire Z Larter
Journal:  Hepatology       Date:  2006-02       Impact factor: 17.425

6.  Coordinated and unique functions of the E-selectin ligand ESL-1 during inflammatory and hematopoietic recruitment in mice.

Authors:  Vinatha Sreeramkumar; Magdalena Leiva; Anika Stadtmann; Christophe Pitaval; Inés Ortega-Rodríguez; Martin K Wild; Brendan Lee; Alexander Zarbock; Andrés Hidalgo
Journal:  Blood       Date:  2013-10-08       Impact factor: 22.113

7.  Imbalance between neutrophil elastase and its inhibitor α1-antitrypsin in obesity alters insulin sensitivity, inflammation, and energy expenditure.

Authors:  Virginie Mansuy-Aubert; Qiong L Zhou; Xiangyang Xie; Zhenwei Gong; Jun-Yuan Huang; Abdul R Khan; Gregory Aubert; Karla Candelaria; Shantele Thomas; Dong-Ju Shin; Sarah Booth; Shahid M Baig; Ahmed Bilal; Daehee Hwang; Hui Zhang; Robin Lovell-Badge; Steven R Smith; Fazli R Awan; Zhen Y Jiang
Journal:  Cell Metab       Date:  2013-04-02       Impact factor: 27.287

8.  p38γ and p38δ reprogram liver metabolism by modulating neutrophil infiltration.

Authors:  Bárbara González-Terán; Nuria Matesanz; Ivana Nikolic; María Angeles Verdugo; Vinatha Sreeramkumar; Lourdes Hernández-Cosido; Alfonso Mora; Georgiana Crainiciuc; María Laura Sáiz; Edgar Bernardo; Luis Leiva-Vega; Elena Rodríguez; Victor Bondía; Jorge L Torres; Sonia Perez-Sieira; Luis Ortega; Ana Cuenda; Francisco Sanchez-Madrid; Rubén Nogueiras; Andrés Hidalgo; Miguel Marcos; Guadalupe Sabio
Journal:  EMBO J       Date:  2016-02-03       Impact factor: 11.598

9.  Neutrophils mediate insulin resistance in mice fed a high-fat diet through secreted elastase.

Authors:  Saswata Talukdar; Da Young Oh; Gautam Bandyopadhyay; Dongmei Li; Jianfeng Xu; Joanne McNelis; Min Lu; Pingping Li; Qingyun Yan; Yimin Zhu; Jachelle Ofrecio; Michael Lin; Martin B Brenner; Jerrold M Olefsky
Journal:  Nat Med       Date:  2012-09       Impact factor: 53.440

Review 10.  TNF and MAP kinase signalling pathways.

Authors:  Guadalupe Sabio; Roger J Davis
Journal:  Semin Immunol       Date:  2014-03-16       Impact factor: 11.130

View more
  25 in total

Review 1.  Inflammation, metaflammation and immunometabolic disorders.

Authors:  Gökhan S Hotamisligil
Journal:  Nature       Date:  2017-02-08       Impact factor: 49.962

Review 2.  Mitogen-Activated Protein Kinase Regulation in Hepatic Metabolism.

Authors:  Ahmed Lawan; Anton M Bennett
Journal:  Trends Endocrinol Metab       Date:  2017-11-08       Impact factor: 12.015

3.  ASK1 inhibition reduces cell death and hepatic fibrosis in an Nlrp3 mutant liver injury model.

Authors:  Susanne Schuster-Gaul; Lukas Jonathan Geisler; Matthew D McGeough; Casey D Johnson; Anna Zagorska; Li Li; Alexander Wree; Vivian Barry; Igor Mikaelian; Lily J Jih; Bettina G Papouchado; Grant Budas; Hal M Hoffman; Ariel E Feldstein
Journal:  JCI Insight       Date:  2020-01-30

Review 4.  Foundations of Immunometabolism and Implications for Metabolic Health and Disease.

Authors:  Gökhan S Hotamisligil
Journal:  Immunity       Date:  2017-09-19       Impact factor: 31.745

5.  Phenotype-Based Screens with Conformation-Specific Inhibitors Reveal p38 Gamma and Delta as Targets for HCC Polypharmacology.

Authors:  Jia Xin Yu; Amanda J Craig; Mary E Duffy; Carlos Villacorta-Martin; Verónica Miguela; Marina Ruiz de Galarreta; Alexander P Scopton; Lisa Silber; Andres Y Maldonado; Alexander Rialdi; Ernesto Guccione; Amaia Lujambio; Augusto Villanueva; Arvin C Dar
Journal:  Mol Cancer Ther       Date:  2019-06-18       Impact factor: 6.261

6.  Dioxin-like and non-dioxin-like PCBs differentially regulate the hepatic proteome and modify diet-induced nonalcoholic fatty liver disease severity.

Authors:  Jian Jin; Banrida Wahlang; Hongxue Shi; Josiah E Hardesty; K Cameron Falkner; Kimberly Z Head; Sudhir Srivastava; Michael L Merchant; Shesh N Rai; Matthew C Cave; Russell A Prough
Journal:  Med Chem Res       Date:  2020-06-07       Impact factor: 1.965

Review 7.  Lipid signaling and lipotoxicity in metaflammation: indications for metabolic disease pathogenesis and treatment.

Authors:  Meric Erikci Ertunc; Gökhan S Hotamisligil
Journal:  J Lipid Res       Date:  2016-06-21       Impact factor: 5.922

Review 8.  Neutrophils as emerging therapeutic targets.

Authors:  Tamás Németh; Markus Sperandio; Attila Mócsai
Journal:  Nat Rev Drug Discov       Date:  2020-01-22       Impact factor: 84.694

9.  p38γ and p38δ reprogram liver metabolism by modulating neutrophil infiltration.

Authors:  Bárbara González-Terán; Nuria Matesanz; Ivana Nikolic; María Angeles Verdugo; Vinatha Sreeramkumar; Lourdes Hernández-Cosido; Alfonso Mora; Georgiana Crainiciuc; María Laura Sáiz; Edgar Bernardo; Luis Leiva-Vega; Elena Rodríguez; Victor Bondía; Jorge L Torres; Sonia Perez-Sieira; Luis Ortega; Ana Cuenda; Francisco Sanchez-Madrid; Rubén Nogueiras; Andrés Hidalgo; Miguel Marcos; Guadalupe Sabio
Journal:  EMBO J       Date:  2016-02-03       Impact factor: 11.598

Review 10.  Brain JNK and metabolic disease.

Authors:  Rubén Nogueiras; Guadalupe Sabio
Journal:  Diabetologia       Date:  2020-11-16       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.